Osiris Therapeutics (OSIR) Tops Q3 Revs, Loss Views
Tweet Send to a FriendGet Alerts OSIR Hot Sheet
Price: $10.85 --0%
EPS Growth %: -100.0%
Financial Fact:
Income before income taxes: -2.74M
Today's EPS Names:
REX, SNPS, SPTN, More
EPS Growth %: -100.0%
Financial Fact:
Income before income taxes: -2.74M
Today's EPS Names:
REX, SNPS, SPTN, More
Trade OSIR Now!
Osiris Therapeutics (NASDAQ: OSIR) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.15 million versus the consensus estimate of $1.89 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- UPDATE: Intuit, Inc. (INTU) Tops Q3 EPS by 4c, Offers Guidance
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
